Changes

An article in ''Nature'' suggests the potential for off-label use of hydroxychloroquine, which was used long ago for [[malaria]] and was first synthesized in 1946, to treat [[coronavirus]] (SARS-CoV-2):<ref name="Nature">https://www.nature.com/articles/s41421-020-0156-0</ref>

An article in ''Nature'' suggests the potential for off-label use of hydroxychloroquine, which was used long ago for [[malaria]] and was first synthesized in 1946, to treat [[coronavirus]] (SARS-CoV-2):<ref name="Nature">https://www.nature.com/articles/s41421-020-0156-0</ref>

{{cquote|[O]ur results show that HCQ [Hydroxychloroquine] can efficiently inhibit SARS-CoV-2 infection in vitro. In combination with its anti-inflammatory function, we predict that the drug has a good potential to combat the disease.}}

{{cquote|[O]ur results show that HCQ [Hydroxychloroquine] can efficiently inhibit SARS-CoV-2 infection in vitro. In combination with its anti-inflammatory function, we predict that the drug has a good potential to combat the disease.}}

Communist China has been developing treatment guidelines, now in their sixth edition, faster than the [[United States]] has.  The Guidelines for the Diagnosis and Treatment of COVID-19 (6th Ed.), which is published by the National Health Commission of communist [[China]], lists chloroquine (CQ) phosphate as a potentially even better drug than HCQ due to a lower cost, more potent effect, and wider availability.<ref name="Nature"/>

Communist China has been developing treatment guidelines, now in their sixth edition, faster than the [[United States]] has.  The Guidelines for the Diagnosis and Treatment of COVID-19 (6th Ed.), which is published by the National Health Commission of communist [[China]], lists chloroquine (CQ) phosphate as a potentially even better drug than HCQ due to a lower cost, more potent effect, and wider availability.<ref name="Nature"/>

{{coronavirus}}

{{coronavirus}}

[[category:coronavirus]]

[[category:coronavirus]]